DICKINSON ANDREW D (EVP, Chief Financial Officer) sold 1.8% of their position (3K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $468.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/16/2026ACC: 0001310204-26-000031
Officer· EVP, Chief Financial Officer
Since Nov 2019
-3K
Net shares
Net seller
$468.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3K
Price / share
$156.22
Trade value
$468.66K
% of position
1.8%
10/15/2026
164.10K→161.10K
Total
Net shares
−3K
Net value
-$468.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/15/2026 | S · Sale | −3K | $156.22 | $468.66K | 1.8% | 164.10K | 161.10K |
| Total | −3K | -$468.66K | ||||||
Derivative Transactions0
No derivative transactions reported